Overview of FDA Draft Guidance on Preclinical Assessment for Investigational Cellular and Gene Therapy Products Mar 07, 2013 Tags: cellular therapeutics, metabolism, ocular, preclinical, research, toxicology In this episode, Sylvie Wise, Research Scientist in the Ocular and Neurosciences department at Charles River Montreal, provides a brief overview of her roundtable discussions to be held at the 2013 Society of Toxicology (SOT) Annual Meeting. listen to podcast
